Internal Medicine, Infectious Disease · Washington, DC
NPI
1194813857
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
765 Kenilworth Ter NE
Washington, DC, 20019
Phone (202) 388-8160
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$6.1M
3,017 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Gebeyehu N Teferi prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 527 prescriptions and refills. In total Gebeyehu N Teferi wrote 3,017 Medicare prescriptions that cost $6.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 527 | 527 | 54 | $2.1M |
| Tivicay Dolutegravir Sodium | 274 | 274 | 31 | $771K |
| Pifeltro Doravirine | 226 | 226 | 24 | $412K |
| Atorvastatin Calcium Generic | 189 | 231 | 30 | $871 |
| Descovy Emtricitabine/Tenofov Alafenam | 171 | 171 | 17 | $385K |
| Amlodipine Besylate Generic | 128 | 156 | 21 | $377 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 127 | 127 | 12 | $498K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 105 | 105 | 12 | $500K |
| Dovato Dolutegravir Sodium/Lamivudine | 79 | 79 | Under 11 | $239K |
| Prezcobix Darunavir/Cobicistat | 73 | 73 | Under 11 | $172K |
| Omeprazole Generic | 72 | 76 | Under 11 | $637 |
| Juluca Dolutegravir/Rilpivirine | 71 | 71 | Under 11 | $261K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 59 | 60 | Under 11 | $2,080 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 49 | 49 | Under 11 | $331 |
| Darunavir Generic | 48 | 48 | Under 11 | $45K |
Brand drugs: 1,945 claims; generic drugs: 1,072 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Gebeyehu N Teferi were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.